IRIS
SINAGRA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.954
AS - Asia 3.349
EU - Europa 2.838
SA - Sud America 677
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 98
OC - Oceania 8
Totale 13.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.552
IT - Italia 1.178
SG - Singapore 1.178
CN - Cina 842
RU - Federazione Russa 645
BR - Brasile 504
VN - Vietnam 466
BD - Bangladesh 266
HK - Hong Kong 208
DE - Germania 207
CA - Canada 190
GB - Regno Unito 165
FR - Francia 110
SE - Svezia 99
IN - India 84
IE - Irlanda 77
AR - Argentina 70
FI - Finlandia 69
NL - Olanda 64
MX - Messico 56
PL - Polonia 55
TR - Turchia 47
ZA - Sudafrica 46
PK - Pakistan 41
ID - Indonesia 38
ES - Italia 36
UA - Ucraina 35
EC - Ecuador 31
JP - Giappone 31
IQ - Iraq 30
CO - Colombia 28
AT - Austria 23
LT - Lituania 22
CR - Costa Rica 20
HN - Honduras 20
SV - El Salvador 20
IL - Israele 19
VE - Venezuela 18
JM - Giamaica 17
SA - Arabia Saudita 17
PR - Porto Rico 15
UZ - Uzbekistan 15
NI - Nicaragua 14
TT - Trinidad e Tobago 13
AE - Emirati Arabi Uniti 12
BE - Belgio 12
CW - ???statistics.table.value.countryCode.CW??? 12
GT - Guatemala 12
MA - Marocco 10
CL - Cile 9
EG - Egitto 9
KE - Kenya 9
CH - Svizzera 8
GP - Guadalupe 8
MY - Malesia 8
TN - Tunisia 8
JO - Giordania 7
OM - Oman 7
SI - Slovenia 6
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
HR - Croazia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
PH - Filippine 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
KR - Corea 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
GR - Grecia 2
MD - Moldavia 2
NO - Norvegia 2
RO - Romania 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
Totale 12.925
Salva come PNG Salva come JPEG
Città #
Dallas 1.834
Singapore 665
San Jose 561
Ashburn 471
Council Bluffs 320
Beijing 277
Milan 197
Hong Kong 189
Ho Chi Minh City 169
Los Angeles 158
New York 134
Rome 122
Phoenix 111
Moscow 104
Santa Clara 100
Hanoi 87
Dublin 76
Chandler 61
Munich 58
São Paulo 58
The Dalles 57
Orem 53
Buffalo 52
Lauterbourg 49
Montreal 47
Warsaw 45
Hefei 44
Naples 39
Frankfurt am Main 36
Helsinki 36
Brooklyn 35
Johannesburg 34
Boardman 31
Bologna 31
Chennai 31
San Mateo 30
Chicago 29
Columbus 29
Pisa 29
Tokyo 29
Denver 28
Atlanta 27
London 27
Mexico City 27
Houston 26
Seattle 26
Ottawa 25
Turin 25
Amsterdam 23
Beauharnois 22
Fairfield 22
Lappeenranta 22
Nuremberg 22
Poplar 22
Haiphong 21
Toronto 21
Boston 20
Cambridge 20
Florence 19
Genoa 19
Istanbul 19
Da Nang 17
Portsmouth 17
Washington 17
San Francisco 16
San José 16
Stockholm 16
West Jordan 16
Brasília 15
Padua 15
Rio de Janeiro 15
Wilmington 15
Ankara 14
Managua 14
Stevenage 14
Tashkent 14
Tel Aviv 14
Kingston 13
Kochi 13
Krefeld 13
Manchester 13
North Bergen 13
San Salvador 13
Belo Horizonte 12
Biên Hòa 12
Querétaro 12
Willemstad 12
Bari 11
Guarulhos 11
Lahore 11
Lawrence 11
Turku 11
Verona 11
Bad Bellingen 10
Brescia 10
Brussels 10
Charlotte 10
Dong Ket 10
Figino 10
Medellín 10
Totale 7.508
Salva come PNG Salva come JPEG
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 752
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 512
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 485
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 368
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 341
[Ten perspectives for research and innovation in cardiac amyloidosis] 320
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 315
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 298
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 277
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 275
[Transcatheter devices for chronic heart failure: state of the art] 271
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 269
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 261
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 261
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 260
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 260
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 258
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 250
Valvular heart disease in patients with cardiac amyloidosis 248
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 243
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 239
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 238
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 237
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 236
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 233
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 230
The chronic heart failure evolutions: Different fates and routes 229
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 228
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 227
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 215
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 210
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 210
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 210
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 208
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 207
Change in prevalence of ATTR variants in Italy: results from a national survey 198
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 198
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 192
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 191
Cardiac amyloidosis: when to suspect and how to confirm 178
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 166
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 156
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 136
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 133
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 116
Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis 114
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis 112
Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC) 110
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: The MECKI-RENAL study 103
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 98
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 97
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis 96
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 91
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 90
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis: The CAUSATIVE Study 82
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study 80
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 74
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 70
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 70
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 63
Electrocardiographic abnormalities in patients with cardiomyopathies 56
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 54
High Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis in Older Adults with Carpal Tunnel Syndrome, Heart Failure or Increased Left Ventricular Mass: The CAPTURE Study 37
Totale 13.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.245
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022128 0 0 0 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/20251.825 31 81 137 52 112 90 243 397 160 70 265 187
2025/20268.713 311 944 1.798 876 686 503 715 488 709 564 589 530
2026/20271.693 260 271 607 555 0 0 0 0 0 0 0 0
Totale 13.042